Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check9 days agoChange DetectedAdded site revision note Revision: v3.4.2. Removed the government funding lapse notice and the previous Revision: v3.4.1.SummaryDifference0.3%

- Check17 days agoChange Detected- Added a site-wide notice about a lapse in government funding and updated operating status. - Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check24 days agoChange DetectedAdded a glossary toggle display and updated footer metadata including Last Update Posted, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Some labels were adjusted for capitalization (No FEAR Act data).SummaryDifference0.2%

- Check38 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a minor administrative update. The trial details and content appear unchanged.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded a centralized Locations section listing study sites by state/province (Alabama, Arizona, California, Colorado, Florida, Illinois, Kentucky, Maryland, Massachusetts, Minnesota, Missouri, North Carolina, Pennsylvania, Texas, Utah) and Ontario. Removed the scattered per-state 'X Locations' blocks and consolidated site information for easier enrollment lookup.SummaryDifference1%

- Check88 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.